SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

4 Nov 2016 07:00

RNS Number : 3068O
Tullett Prebon PLC
04 November 2016
 

4 November 2016

Tullett Prebon plc

 

 

 

Q3 Trading Update

 

Tullett Prebon plc is today issuing a trading update in relation to the period from 1 July to 30 September 2016.

 

Revenue in the third quarter to 30 September 2016 of £216m was 15% higher than the £188m revenue for the same period last year, and 4% higher at constant exchange rates. In the nine months to September, revenue of £647m was 7% higher than the £603m revenue for the same period last year, and 2% higher at constant exchange rates.

Reported revenue grew strongly in the third quarter due to the impact of foreign exchange, with around 60% of the group's revenue denominated in US dollars. During the period we have benefited from volatility associated with political uncertainty and speculation around the potential for further interest rate increases.

 

In the first nine months we continued to benefit from our acquisitions in Energy and Commodities as the division increased revenue 10% year on year at constant exchange rates. Information Sales and RMS have continued to see strong growth in the current quarter, with an increase of 28% in revenue (at constant exchange rates). In the first nine months their revenue increased 20% (at constant exchange rates).

 

In November 2015, we announced the proposed acquisition of the global hybrid voice broking and information businesses of ICAP plc. We are continuing to work with ICAP towards securing the outstanding regulatory approvals for completion of the transaction, including from the FCA.

 

John Phizackerley, Tullett Prebon CEO, said: "This has been a satisfactory quarter, with a number of products and regions showing gains. While some trading conditions remain challenging, our strategy of diversification and cost control is proving effective."

 

 

Notes to Editors

 

Tullett Prebon (www.tullettprebon.com) is one of the world's leading interdealer brokers and operates as an intermediary in wholesale financial markets facilitating the trading activities of its clients in seven major product groups: Energy & Commodities, Rates, Volatility, Treasury, Non-Banking, Credit and Equities.

With offices in 24 countries, Tullett Prebon operates voice, hybrid, electronic, volume matching, algorithmic matching and risk mitigation platforms, to accommodate the needs of its clients, and to satisfy the regulatory driven evolution of the marketplace. In addition to its brokerage services, Tullett Prebon offers a variety of market information services through its IDB Market Data division, Tullett Prebon Information.

Tullett Prebon has its principal offices in London, New Jersey, Hong Kong, Singapore and Tokyo, with other offices, joint ventures and affiliates in Bangkok, Connecticut Dubai, Frankfurt, Geneva, Houston, Jakarta, Johannesburg, Luxembourg, Madrid, Manama, Manila, Mexico City, Mumbai, New York, Paris, São Paulo, Seoul, Shanghai, Sydney, Toronto, Vienna and Warsaw.

Enquiries:

Tullett Prebon plc

 

Analysts/investors:

Sam Dobbyn, +44 (0)20 7200 7147

sdobbyn@tullettprebon.com

 

Media:

Rebecca Shelley, +44 (0)20 7200 7750

rshelley@tulletprebon.com

 

Brunswick Group

 

Kim Fletcher

Eilis Murphy

+44 (0)20 7404 5959

tullettprebon@brunswickgroup.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKXLFBQFFBFBE
Date   Source Headline
4th Dec 20184:15 pmRNSHolding(s) in Company
3rd Dec 20183:59 pmRNSHolding(s) in Company
16th Nov 20184:08 pmRNSHolding(s) in Company
16th Nov 20183:42 pmRNSDirector Declaration
14th Nov 201812:19 pmRNSHolding(s) in Company
14th Nov 201811:03 amRNSDirector/PDMR Shareholding
13th Nov 20183:52 pmRNSDirector/PDMR Shareholding
9th Nov 20183:29 pmRNSHolding(s) in Company
7th Nov 201812:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20183:23 pmRNSHolding(s) in Company
2nd Nov 20187:00 amRNSAcquisition
2nd Nov 20187:00 amRNSTrading Statement
25th Oct 201810:06 amRNSHolding(s) in Company
2nd Oct 20184:24 pmRNSDirector/PDMR PCA Share Acquisition
25th Sep 20184:35 pmRNSDirector/PDMR Shareholding
25th Sep 20184:34 pmRNSDirector/PDMR Shareholding
18th Sep 20183:20 pmRNSDirector/PDMR Shareholding
12th Sep 20185:14 pmRNSHolding(s) in Company
10th Sep 201812:00 pmRNSHolding(s) in Company
3rd Sep 20187:00 amRNSDirector/PDMR Shareholding
3rd Sep 20187:00 amRNSDirectorate Change
28th Aug 201811:47 amRNSDirector/PDMR Shareholding
10th Aug 201812:39 pmRNSDirector/PDMR Shareholding
9th Aug 20181:12 pmRNSDirector/PDMR Shareholding
7th Aug 20183:38 pmRNSDirector/PDMR Shareholding
7th Aug 20181:08 pmRNSDirector/PDMR Shareholding
7th Aug 20187:00 amRNSFinancial and Interim Management Report
3rd Aug 20185:48 pmRNSHolding(s) in Company
3rd Aug 20188:23 amRNSHolding(s) in Company
1st Aug 20185:26 pmRNSHolding(s) in Company
31st Jul 201811:00 amRNSListing Rule 9.6.14R(2) Notification
13th Jul 20184:32 pmRNSHolding(s) in Company
12th Jul 20183:36 pmRNSHolding(s) in Company
10th Jul 20187:00 amRNSTrading update and directorate changes
6th Jul 20182:59 pmRNSHolding(s) in Company
3rd Jul 20184:06 pmRNSHolding(s) in Company
3rd Jul 20184:06 pmRNSHolding(s) in Company
26th Jun 20185:05 pmRNSDirector/PDMR Shareholding
21st Jun 20181:00 pmRNSDirectorate Change
18th Jun 201810:06 amRNSDirector/PDMR Shareholding
30th May 20187:00 amRNSTP ICAP announces Chairman's intention to retire
30th May 20187:00 amRNSDirectorate Change
18th May 20183:04 pmRNSHolding(s) in Company
15th May 20184:38 pmRNSHolding(s) in Company
11th May 20183:56 pmRNSDirector/PDMR Shareholding
10th May 20184:11 pmRNSResult of AGM
10th May 20187:00 amRNSAGM Statement and Trading Update
9th Apr 20183:51 pmRNSDirector/PDMR Shareholding
5th Apr 20183:13 pmRNSAnnual Financial Report
29th Mar 20187:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.